Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
Provided By GlobeNewswire
Last update: Jun 11, 2025
CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced the appointment of Claire Mazumdar, Ph.D., to the Company’s Board of Directors, effective June 9, 2025.
Read more at globenewswire.com
